Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study. Rev Diabet Stud [Internet]. 2025 Sep. 14 [cited 2025 Oct. 7];:693-700. Available from: https://www.diabeticstudies.org/index.php/RDS/article/view/628